RYSTIGGO 420 MG in 3 ML Injection

RxCUI: 2685615
RxNorm name: RYSTIGGO 420 MG in 3 ML Injection
Display name: RYSTIGGO 420 MG in 3 ML Injection
Full name: RYSTIGGO 420 MG in 3 ML Injection
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:38:54

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
761286	Rystiggo	rozanolixizumab-noli	351(a)	Rx	2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
RYSTIGGO	ROZANOLIXIZUMAB	UCB, Inc.	3c0eb8c2-c042-4954-b451-3baa77f5e6d1	2026-01-20	Warnings, Adverse reactions	Exact identifier rxcui: 2685615

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
3c0eb8c2-c042-4954-b451-3baa77f5e6d1	RYSTIGGO 420 MG in 3 ML Injection	PSN	10	These highlights do not include all the information needed to use RYSTIGGO safely and effectively. See full prescribing information for RYSTIGGO. RYSTIGGO ® (rozanolixizumab-noli) injection, for subcutaneous use Initial U.S. Approval: 2023	20260120
3c0eb8c2-c042-4954-b451-3baa77f5e6d1	Rystiggo 420 MG per 3 ML Injection	SY	10	These highlights do not include all the information needed to use RYSTIGGO safely and effectively. See full prescribing information for RYSTIGGO. RYSTIGGO ® (rozanolixizumab-noli) injection, for subcutaneous use Initial U.S. Approval: 2023	20260120
3c0eb8c2-c042-4954-b451-3baa77f5e6d1	3 ML rozanolixizumab-noli 140 MG/ML Injection [Rystiggo]	SBD	10	These highlights do not include all the information needed to use RYSTIGGO safely and effectively. See full prescribing information for RYSTIGGO. RYSTIGGO ® (rozanolixizumab-noli) injection, for subcutaneous use Initial U.S. Approval: 2023	20260120